A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/04 (2006.01)
Patent
CA 2538633
Radiolabeled epidermal growth factor receptor tyrosine kinase (EGFR-TK) irreversible inhibitors and their use as biomarkers for medicinal radioimaging such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) and as radiopharmaceuticals for radiotherapy are disclosed.
L'invention concerne des inhibiteurs irréversibles de la tyrosine kinase du récepteur du facteur de croissance épidermique (EGFR-TK) et leurs utilisations en tant que biomarqueurs en radioimagerie médicale telle que la tomographie par émission de positrons (TEP) et la tomographie monophotonique d'émission (SPECT) et en tant qu'agents radiopharmaceutiques de radiothérapie.
Ben-David Iris
Levitzki Alexander
Mishani Eyal
Ortu Giuseppina
Rozen Yulia
Hadasit Medical Research Services And Development Ltd.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Yissum Research Development Company Of The Hebrew University Of
LandOfFree
Radiolabeled anilinoquinazolines and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled anilinoquinazolines and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled anilinoquinazolines and their use in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1555802